ClinicalTrials.Veeva

Menu

Gait Evaluation in Haemophiliac Patients (GAIT_GENERAL)

C

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Status

Completed

Conditions

Hemophilia B
Hemophilia A

Study type

Observational

Funder types

Other

Identifiers

NCT00824798
READ-LOBET-02

Details and patient eligibility

About

Joint damage secondary to recurrent haemarthroses and chronic synovitis represents the commonest clinical manifestation of haemophilia. Incapacitating pain, loss of joint stability and mobility, axial deviation, deterioration and decreased function are the most frequent complains in patients with severe haemophilic arthropathy In this context, the purpose of our study is to examine and analyse specific changes in gait in patients suffering from haemophilic arthropathy and determine the impact on health-related quality of life in terms of conceptual components of pain and stiffness, psychosocial stress, disability, and activity limitations as recommended by the International Classification of Function (ICF) recently published by the World Health Organization.

Enrollment

31 patients

Sex

Male

Ages

5 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • haemophilia A or B
  • aged more than 4 years

Exclusion criteria

  • impossibility to walk on a treadmill
  • recent joint haemarthrosis or muscle haematoma

Trial design

31 participants in 1 patient group

haemophiliacs A and B
Description:
haemophiliacs A and B mild, moderate or severe from 4 to 80 years old, with or without inhibitors.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems